STOCKHOLM, March 1, 2022 /PRNewswire/ Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced new preclinical data on its anti-inflammatory IL1RAP-binding antibody CAN10 showing
According to the CDC data tracker, pediatric COVID deaths have doubled since November 2021, underscoring the deadly consequences from all variants of the SARS-CoV-2 for this population.